Corteva, a publicly traded, global pure-play agriculture company, completed the acquisition of Stoller, an independent biological company, for $1.2bn. "These acquisitions illustrate Corteva's commitment to providing farmers with sustainable solutions that bring value and productivity to the farm. We are pleased to officially welcome Symborg and Stoller employees to Corteva. We believe their knowledge and expertise, combined with Corteva's innovations capabilities, will come together to form a leading Biologicals Business ready to accelerate and grow with the rapidly expanding biologicals market," Chuck Magro, Corteva CEO.